SynthesisFrontiers in neurology2025
Surgical management of sellar arachnoid cyst: state of the art and systematic review.
Synthesis in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sellar arachnoid cysts are rare intracranial lesions with variable clinical presentations, making their optimal management uncertain. This systematic review consolidates current knowledge on their epidemiology, radiological features, surgical management, and outcomes. Materials and methods: A literature search, following PRISMA-P 2015 guidelines, was conducted in MEDLINE/PubMed, Google Scholar, and Ovid Embase. Studies published in English from the year 2000 onwards were included. Data extraction focused on patient demographics, clinical presentation, surgical approaches, outcomes, and complications. Results: Thirty-three studies (16 case reports, 17 case series) met the inclusion criteria, encompassing 154 patients (59.34% female, mean age 51.48 years). The most common symptoms were visual disturbances (57.14%), headaches (35.06%), and endocrine disorders (30.52%). Surgical intervention details were available for 144 patients. Endoscopic transsphenoidal surgery was the most frequent approach (73.38%), followed by microscopic transsphenoidal surgery (11.69%). Various sellar reconstruction techniques were employed, including fascia lata, abdominal fat grafts, and nasoseptal flaps. The mean follow-up was 42.90 months. Postoperative complications occurred in 15.58% of cases, with cerebrospinal fluid leaks (7.14%) being the most common. Cyst recurrence was observed in 6.49% of patients. Most individuals with visual disturbances and headaches improved postoperatively, while endocrine function recovery was less consistent. Discussion and conclusions: SACs can cause significant morbidity due to mass effect and endocrine dysfunction. Endoscopic transsphenoidal surgery is the preferred treatment, but effective reconstruction is crucial to minimizing cerebrospinal fluid leaks. The recurrence rate highlights the importance of long-term follow-up. Future research should aim to standardize management protocols for improved outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.